REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/16/2026
Back to search
Official data from USPTO
SEE MORE. TREAT SMARTER.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEE MORE. TREAT SMARTER.
ST13
US500000086764515Class
5, 10, 41
Filing
86764515
Registration
5205582
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
05/17/2026
Trademark type
Word
Nice classes
5, 10, 41
Filing date
09/22/2015
Registration date
05/16/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/15/2025
Last transaction
05/17/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/23/2015
First use in commerce
12/23/2015
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
BROOKSHIRE, DAVID AARON
Current location
Historical data usage
Holders and representatives
Holders
BTG International Limited
Representatives
Lori A. Ruhly Quarles & Brady LLP
Technical classification
Nice Classes
Class 5Class 10Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalmedicinal substancespharmaceutical preparations for the treatment of cancerpharmaceutical preparations and substances for the treatment of thrombosisembolismsdrug delivery agentspreparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolisation; pharmaceutical preparations and substances for embolisation of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; transarterial chemoembolisation pharmaceutical preparations ; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substancestherapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer
Class 10
Surgicalmedical apparatus and instrumentsmedical deviceapparatus and instruments for treating cancer; drug delivery embolisation apparatusinstruments and systems; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instrumentscathetersinjection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatusinstruments and systems comprising surgical and medical instruments for embolizationembolic devices for use in treating cancer and tumorsembolic devices for treating arteriovenous malformations (AVMs) of the bodyembolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments namelya drug delivery system comprised of injection syringes and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory systemcathetersinjection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolizationmedical devices in the nature of particlesembolic microspheres for embolization ; surgical and medical apparatus and instruments for embolisationembolisation apparatusinstruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for use in the circulatory system; surgical and medical apparatus for use in treatment ofarterio-venous malformations; syringes for use in treatment ofarterio-venous malformations
Class 41
Educationdevelopingarranging and conducting educational seminarsworkshops and programs and providing courses of instruction in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; provision of educational content namelyproviding on-line instruction in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; providing computerelectronic and online databases featuring information about medical education in the field of healthcaremedicinemedical treatment and patient care; training in the use and operation of pharmaceutical productspharmaceutical preparationsradiopharmaceutical preparationsmedical devicesmedical imaging apparatus and medical research apparatus and consultation relating thereto; educational servicesconducting live and online seminarsclassesworkshopslecturespanel discussionstraining programs in the fields of healthcarethe use of pharmaceutical and medical devicesmedical researchsurgerymedical sciencemedicine and medical diseasesdisorders and related treatments; Educational servicesproviding non-downloadable webinars in the fields of healthcarethe use of pharmaceuticals and medical devicesmedical researchsurgerymedical sciencemedicinemedical diseasesdisorders and related treatments; educational servicesconducting live and online seminarsclassesworkshopslecturespanel discussions and training in the field of health; educational servicesproviding non-downloadable webinars in the field of health; education servicesconducting online and telephonic instruction and courses in the fields of health and medical issues
Publications
History of USPTO decisions and trademark events.
51 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/15/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/15/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/09/2024
XXXX
POST REGISTRATION ACTION CORRECTION
10/09/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/02/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
05/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/20/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/16/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/16/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/16/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/29/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/29/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/29/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/29/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/29/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/11/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/08/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/17/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/16/2017
IUAF
USE AMENDMENT FILED
03/06/2017
EISU
TEAS STATEMENT OF USE RECEIVED
03/06/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2016
PUBO
PUBLISHED FOR OPPOSITION
07/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
06/02/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/02/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
06/02/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/17/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2016
GNRT
NON-FINAL ACTION E-MAILED
01/09/2016
CNRT
NON-FINAL ACTION WRITTEN
01/09/2016
DOCK
ASSIGNED TO EXAMINER
01/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2015
NWAP
NEW APPLICATION ENTERED
09/25/2015
Continuous trademark protection
Get notified about every new filing that threatens SEE MORE. TREAT SMARTER. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.